Ginwa Enterprise Group Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ginwa Enterprise Group Inc. with three other
companies in this sector in China:
Wuhan Hiteck Biological Pharma Co Ltd
sales of 750.26 million Chinese Renmimbi [US$108.74 million]
of which 99%
was Medicine Manufacture),
Shanghai Fudan Forward S&T Co Ltd
(735.73 million Chinese Renmimbi [US$106.63 million]
of which 64%
was Industrial), and
Beijing Science Sun Pharmaceutical Co Ltd
(749.99 million Chinese Renmimbi [US$108.70 million]
of which 100%
was Phamaceutical Manufacturing Industry).
During the year ended December of 2017, sales at
Ginwa Enterprise Group Inc. were 756.60 million Chinese Renmimbi (US$109.65 million).
increase of 13.6%
versus 2016, when the company's sales were 666.23 million Chinese Renmimbi.
Sales of Pharmaceutical Industry saw an increase
15.0% in 2017, from
486.20 million Chinese Renmimbi to 558.97 million Chinese Renmimbi.